Paris, France and Camberley, UK – 29 July 2021 – Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), a leading international specialist in clinical diagnostics, announces the appointment of David
Novacyt S.A. (NCYT.L) Full year 2020 results and update on strategy
Transformational performance in 2020 Continued strong demand for COVID-19 testing in 2021
Novacyt S.A. (NCYT.L) Update on Notice of 2020 Full Year Results
Paris, France and Camberley, UK – 18 June 2021 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it will report its audited
Novacyt S.A. (NCYT.L) DHSC Dispute Update
Paris, France and Camberley, UK – 21 May 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update to its ongoing dispute with
Novacyt S.A. (NCYT.L) Inclusion of SNPsig in the NHS England Framework
Inclusion of SNPsig® SARS-CoV-2 PCR genotyping portfolio in the NHS England Framework and expansion of SNPsig® product range
Novacyt S.A. (NCYT.L) Novacyt donates 1 million COVID-19 tests to UNICEF
Donation supports testing efforts to help ensure continued access to essential services for children and their families
Novacyt S.A. (NCYT.L) R&D and UK operational update
Paris, France and Camberley, UK – 23 April 2021 – Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), an international specialist in clinical diagnostics.
Novacyt S.A. (NCYT.L) Trading Update
Paris, France and Camberley, UK – 9 April 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on its supply contract with
Novacyt S.A. (NCYT.L) Full Year 2020 Trading Update
Paris, France and Camberley, UK – 29 January 2021 – Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), an international specialist in clinical diagnostics, announces an unaudited trading update for
Novacyt S.A. (NCYT.L) Director/PDMR Shareholding
Paris, France and Camberley, UK – 12 November 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on
Novacyt S.A. (NCYT.L) Liquidity Agreement and Total Voting Rights
Paris, France and Camberley, UK – 2 November 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its monthly update in relation to ordinary